Clinical Specification

Indication: Intradermal injection for cheek skin smoothness.
Device Class: III Medical Device.
Sterile: Steam sterilized gel.

Primary Endpoint Met: In a pivotal clinical study, 63% of patients maintained a ≥1-point improvement on the Allergan Cheek Smoothness Scale (ACSS) at month 6, compared to 28% in the control group.

High Glow Satisfaction: At 6 months, 91% of participants reported satisfaction with how refreshed and healthy their skin appeared. Secondary endpoints confirmed significant improvements in skin hydration and radiance.

Packaging Specifications

01

Site Preparation

Aseptic cleansing of the mid-face and malar regions. Topical anesthesia is optional due to integrated 0.3% lidocaine.

02

Injection Technique

Multiple microdroplet injections (0.01 to 0.05 mL per point) delivered into the mid-to-deep dermis, spaced 0.5 to 1 cm apart.

03

Post-Treatment

Gentle palpation to ensure even distribution. Avoid high-intensity exercise and ethanol consumption for 24 hours post-procedure.

Safety Compliance & Contraindications

Prescription Use Only: This product is restricted for sale to and use by licensed healthcare professionals only. Verification of medical credentials is required prior to shipping.

Contraindications: Do not administer to patients with a history of severe allergies (anaphylaxis) or allergies to Gram-positive bacterial proteins or lidocaine.

Adverse Reactions: Common side effects observed in clinical trials include redness, swelling, bruising, and tenderness at the injection site, typically resolving within 7 days.

Authentication: All units are traceable via batch number and expiry date provided on the external packaging. Guaranteed authentic JUVÉDERM® product line.